Genomic Valley Biotech Ltd

BSE: 539206

15

total announcements

539206.BO · 15 min delayed

AnnouncementsDiscussion
BSECompany UpdateFundraise3 Nov 2026

Genomic Valley Biotech Ltd

Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Shareholders of Genomic Valley Biotech Ltd ("Target Company").

Genomic Valley Biotech Ltd has received a draft letter of offer from Fintellectual Corporate Advisors Pvt Ltd for an open offer to acquire up to 7,94,170 shares, representing 26% of the voting share capital, at ₹ 30 per share.

Read more →📎 1 attachment
BSEBoard MeetingResults30 Oct 2026

Genomic Valley Biotech Ltd

Please find enclosed herewith Outcome of Board Meeting Pursuant to regulation 30 of Sebi (LODR)Regulation, 2015 held on today i.e. 30th October 2026

Genomic Valley Biotech Ltd has announced the outcome of its board meeting held on 30th October 2026, where the board considered and approved the standalone un-audited financial results for the quarter and half year ended 30th September 2026. The company has submitted a limited review report from its statutory auditor, ANDROS & CO., which has reviewed the financial results and found no material misstatement.

Read more →📎 1 attachment
BSECompany UpdateFundraise27 Oct 2026

Genomic Valley Biotech Ltd

Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation 13(4), Regulation 14(3), Regulation 15(2) and other applicable Regulations of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, to the Public Shareholders of Genomic Valley Biotech Ltd ("Target Company").

Genomic Valley Biotech Ltd has received an open offer from Mr. Pankaj Grover and Mr. Abhishek Gupta to acquire up to 7,94,170 equity shares from the shareholders of the company.

Read more →📎 1 attachment
BSEBoard MeetingResults21 Oct 2026

Genomic Valley Biotech Ltd

Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve the unaudited financial results (standalone) of the Company for the quarter and half year ended 30th September 2026.

Genomic Valley Biotech Ltd has scheduled a Board Meeting on 30/10/2026 to consider and approve the unaudited financial results for the quarter and half year ended 30/09/2026.

Read more →📎 1 attachment
BSECompany Update▼ NegativeM&A20 Oct 2026

Genomic Valley Biotech Ltd

Disclosure under Regulation 30 and Regulation 30A of the SEBI (LODR) Regulations, 2015 regarding Mr. Yogesh Agrawal (hereinafter referred to as the "Promoters" or "Promoter Sellers") of the Company has entered into Share Purchase Agreement ("SPA") with Mr. Pankaj Grover and Mr. Abhisek Gupta (hereinafter referred to as "Acquirers") pursuant to which the promoters sellers propose to sell entire of their shareholding in the company to the acquirers.

Genomic Valley Biotech Ltd's promoter, Yogesh Agrawal, has entered into a Share Purchase Agreement with Pankaj Grover and Abhisek Gupta to sell their entire shareholding in the company. The transaction will result in the acquirers acquiring control over the company and will attract an obligation to make an open offer to public shareholders.

Read more →📎 1 attachment
BSECompany UpdateM&A19 Oct 2026

Genomic Valley Biotech Ltd

Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement ("PA") under Regulation 3(1) and Regulation 4 read with Regulation 13(1), 14, and 15 (1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto for the attention of the Public Shareholders of Genomic Valley Biotech Ltd ("Target Company").

Genomic Valley Biotech Ltd has received a public announcement from Fintellectual Corporate Advisors Pvt Ltd regarding an open offer for the acquisition of up to 7,94,170 equity shares, representing 26.00% of the voting share capital, by Mr. Pankaj Grover and Mr. Abhisek Gupta at a price of ₹30 per share.

Read more →📎 1 attachment
BSEInsider Trading / SAST28 Sept 2026

Genomic Valley Biotech Ltd

Please find enclosed herewith intimation for closure of trading window.

Genomic Valley Biotech Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the announcement of its un-audited financial results for the quarter and half year ended on September 30, 2026, in accordance with SEBI regulations.

Read more →📎 1 attachment
BSEOthersRegulatory31 Aug 2026

Genomic Valley Biotech Ltd

Intimation of approval of Extension of time for holding Annual General Meeting (AGM) of the company for the financial year ended on 31st March 2026, pursuant to regulation 30 of SEBI (Listing ....

Genomic Valley Biotech Ltd has received approval from the Registrar of Companies, Haryana to extend the time for holding its Annual General Meeting (AGM) for the financial year ended 31st March 2026 by 3 months, from 30th September 2026 to 31st December 2026.

Read more →📎 1 attachment
BSEResultResults14 Aug 2026

Genomic Valley Biotech Ltd

Unaudited financial results for Quarter ended on 30 June 2026.

Genomic Valley Biotech Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company's management has approved the results, which have been reviewed by the statutory auditor ANDROS & CO. The results are based on the recognition and measurement principles laid down in Indian Accounting Standard 34 (Ind AS 34) and have been prepared in accordance with the Listing Regulations.

Read more →📎 1 attachment